Shots:
2023 had been a great year for the biopharma industry despite several imposed restrictions from the IRA and inflation
With several swaying factors impacting the biopharma industry, including social, economic, regulatory and others, some of the noteworthy trends that emerged in 2024 and are shaping the ways biopharma companies operate
The article explores four key…
